Scholarly Works - Preprints
Preprint
·
May 26, 2026
The DNA damage response kinase ATR restrains CDK1 activity during S and G2 phases of the cell cycle, confining CDK1-driven processes to mitosis. ATR kinase inhibitors were originally developed to potentiate chemotherapy-induced DNA damage at stalled replic ...
Full text
Link to item
Cite
Preprint
·
October 28, 2022
AbstractBackground
Approximately half of all cancer patients receive radiotherapy and, as cancer survivorship rat ...
Full text
Cite
Preprint
·
2022
AbstractHead and neck squamous cell carcinoma (HNSCC) is a heterogenous disease where, in advanced stages, clinical and pathological stages do not correlate with outcome. Molecular and genomic biomarkers for HNSCC classification have sh ...
Full text
Cite